What is the projected market valuation for the South Korea computer vision-healthcare market by 2035?

The projected market valuation for the South Korea computer vision-healthcare market is $210.08 Million by 2035. Read More

What was the overall market valuation in 2024?

The overall market valuation in 2024 was $47.19 Million. Read More

What is the expected CAGR for the South Korea computer vision-healthcare market during the forecast period 2025 - 2035?

The expected CAGR for the South Korea computer vision-healthcare market during the forecast period 2025 - 2035 is 14.54%. Read More

Which companies are considered key players in the South Korea computer vision-healthcare market?

Key players in the market include Siemens Healthineers, GE Healthcare, Philips Healthcare, IBM Watson Health, Canon Medical Systems, NVIDIA Corporation, Zebra Medical Vision, and Aidoc. Read More

How much is the Medical Imaging segment valued at in 2025?

The Medical Imaging segment is valued at $45.0 Million in 2025. Read More

What is the valuation of the Patient Monitoring segment in 2025?

The Patient Monitoring segment is valued at $40.0 Million in 2025. Read More

What is the projected valuation for the Software component in 2035?

The projected valuation for the Software component is $90.0 Million in 2035. Read More

Which end-use segment is expected to have the highest valuation in 2025?

The Hospitals end-use segment is expected to have the highest valuation at $66.0 Million in 2025. Read More

South Korea Computer Vision Healthcare Market

Q: What are the main application segments in the South Korea computer vision-healthcare market?

The main application segments include Medical Imaging, Surgical Robotics, Disease Diagnosis, Patient Monitoring, and Drug Discovery. Read More

Q: What technology segments are driving growth in the South Korea computer vision-healthcare market?

Driving technology segments include Deep Learning, Machine Learning, Image Processing, Facial Recognition, and 3D Imaging. Read More

ID: MRFR/HC/49666-HCR

200 Pages

Vikita Thakur

Last Updated: February 06, 2026

South Korea Computer Vision Healthcare Market Research Report: Size, Share, Trend Analysis By Applications (Medical Imaging, Surgical Robotics, Disease Diagnosis, Patient Monitoring, Drug Discovery), By Technology (Deep Learning, Machine Learning, Image Processing, Facial Recognition, 3D Imaging), By End Use (Hospitals, Diagnostic Centers, Research Laboratories, Pharmaceutical Companies, Healthcare IT) and By Component (Software, Hardware, Services) - Growth Outlook & Industry Forecast 2025 To 2035

South Korea Computer Vision Healthcare Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Application (USD Million)
  1. 4.1.1 Medical Imaging
  2. 4.1.2 Surgical Robotics
  3. 4.1.3 Disease Diagnosis
  4. 4.1.4 Patient Monitoring
  5. 4.1.5 Drug Discovery
2. 4.2 Pharmaceutical, BY Technology (USD Million)
  1. 4.2.1 Deep Learning
  2. 4.2.2 Machine Learning
  3. 4.2.3 Image Processing
  4. 4.2.4 Facial Recognition
  5. 4.2.5 3D Imaging
3. 4.3 Pharmaceutical, BY End Use (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Centers
  3. 4.3.3 Research Laboratories
  4. 4.3.4 Pharmaceutical Companies
  5. 4.3.5 Healthcare IT
4. 4.4 Pharmaceutical, BY Component (USD Million)
  1. 4.4.1 Software
  2. 4.4.2 Hardware
  3. 4.4.3 Services
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Siemens Healthineers (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 GE Healthcare (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Philips Healthcare (NL)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 IBM Watson Health (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Canon Medical Systems (JP)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 NVIDIA Corporation (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Zebra Medical Vision (IL)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Aidoc (IL)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY END USE
5. 6.5 SOUTH KOREA MARKET ANALYSIS BY COMPONENT
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY TECHNOLOGY, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY COMPONENT, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY COMPONENT, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY END USE, 2025-2035 (USD Million)
  4. 7.2.4 BY COMPONENT, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea Pharmaceutical Market Segmentation

Pharmaceutical By Application (USD Million, 2025-2035)

Medical Imaging
Surgical Robotics
Disease Diagnosis
Patient Monitoring
Drug Discovery

Pharmaceutical By Technology (USD Million, 2025-2035)

Deep Learning
Machine Learning
Image Processing
Facial Recognition
3D Imaging

Pharmaceutical By End Use (USD Million, 2025-2035)

Hospitals
Diagnostic Centers
Research Laboratories
Pharmaceutical Companies
Healthcare IT

Pharmaceutical By Component (USD Million, 2025-2035)

Software
Hardware
Services

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”